DDAVP


Also found in: Dictionary, Medical.
AcronymDefinition
DDAVPDesmopressin Acetate (synthetic analogue of the pituitary hormone 8-arginine vasopressin)
DDAVP1-Desamino-8d-Arginine Vasopressin
DDAVPDeamino-Delta-D-Arginine Vasopressin (hematology)
References in periodicals archive ?
AVPR2 mutations causing CNDI can vary in their functional severity; clinical symptoms and the response to DDAVP can be diverse.
DDAVP is normally given during the water deprivation test to differentiate between CDI and NDI, but since the patient demonstrated an increase in urine osmolality, DI was ruled out and DDAVP was not given.
Prevention and treatment of bleeding in AVWS secondary to an IgM or IgG monoclonal gammopathy can be accomplished with DDAVP and/or vWF/factor VIII replacement products.
Patient indeed developed a significant aquaretic phase when electrolyte-free water and DDAVP were promptly given to divert hyponatremia overcorrection.
Our study suffered from some limitations, such as that we have not evaluated the WF:Ac assay for acquired von Willebrand syndrome and its satisfactory use for monitoring of VWF post-treatment with DDAVP (desmopressin) and/or VWF concentrate.
Contract awarded for Leodrin 70; Selcal D; Colostomy Bags; Ddavp
Para as mulheres que nao tiveram controle satisfatorio da menorragia com os metodos hormonais ou que desejam gestar, terapias com medicamentos antifibrinoliticos (acido aminocaproico e acido tranexamico), concentrados de fatores de coagulacao e desmopressina (DDAVP) podem ser utilizados (A).
USA has been granted final approval by the FDA for desmopressin acetate tablets, 0.1 mg and 0.2 mg, the therapeutic equivalent of DDAVP. Other Abbreviated New Drag Applications that have recently been approved for Glenmark are for levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg for calcipotriene cream 0.005%.
Desmopressin or 1-deamino-8-D-arginine vasopressin (DDAVP) is a synthetic analog of vasopressin.
Desmopressin (DDAVP) has been reported to shorten the prolonged bleeding time of individuals taking antiplatelet agents such as aspirin and ticlopidine.
In nocturia, a new low-dose oral desmopressin tablet (DDAVP) may allow more patients with nocturnal polyuria to be treated.
Combined treatment with enuresis alarm and DDAVP for nocturnal enuresis.